Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence — Revenue, Volume, Production, Trade Analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Product type Segment | Endoscopic hemostatic devices, Thermal devices, Closure devices |
| GI tract division Segment | Upper GI Tract, Lower GI Tract |
| Onset Segment | Acute, Chronic |
|---|---|
| End-User Segment | Hospitals/clinics, Ambulatory surgical centers, Others. |
| Regions & Countries |
|
The increasing adoption of minimally invasive procedures for the treatment of gastrointestinal bleeding is propelling market growth. Excessive smoking and alcohol consumption from people drive the growth of the gastrointestinal bleeding treatment market
High treatment costs treatment may hamper the market
Significant innovation and product development efforts by key players are a significant opportunity for the market
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
Major market participants who are essential in determining consumer preferences and market dynamics have a major impact on the gastrointestinal bleeding treatment market. These major players provide consumers with easy access to a vast array of wardrobe options through their extensive retail networks and online platforms. Product adoption has increased as a result of their strong worldwide presence and well-known brand, which has also increased consumer trust and loyalty. In addition, these industry titans never stop funding R&D, bringing cutting-edge styles, materials, and practical features to clothing wardrobes to meet changing customer demands and preferences. These big players' combined efforts have a big impact on the market's future direction and level of competition.
| Company | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Boston Scientific Corporation | ••• | ••• | ••• | ••• |
| Olympus Corporation | ••• | ••• | ••• | ••• |
| CONMED Corporation | ••• | ••• | ••• | ••• |
| Cook Medical | ••• | ••• | ••• | ••• |
| Ovesco Endoscopy AG | ••• | ••• | ••• | ••• |
| Erbe Elektromedizin GmbH | ••• | ••• | ••• | ••• |
| STERIS PLC | ••• | ••• | ••• | ••• |
| US Medical Innovations LLC. | ••• | ••• | ••• | ••• |
Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.
Request company profile for validation →According to cognitive market research, the global gastrointestinal bleeding treatment market size was valued at USD xx billion in 2024 and is expected to reach USD xx billion at a CAGR of xx% during the forecast period.
Gastrointestinal bleeding refers to blood loss that occurs within the digestive organs. The high prevalence of upper gastrointestinal bleeding, the rise in applications of endoscopic hemostasis, and the growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market.
The high prevalence of upper gastrointestinal bleeding, the rise in applications of endoscopic hemostasis, and the growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market. Because of unhealthful eating habits, peptic ulcer cases are widespread worldwide, regardless of location. In addition, the prevalence of other stomach disorders including Peptic Ulcer Disease (PUD) is rising globally, which is driving up demand for gastrointestinal gadgets. Major market participants who are essential in determining consumer preferences and market dynamics have a major impact on the gastrointestinal bleeding treatment market.
The high prevalence of upper gastrointestinal bleeding, the rise in applications of endoscopic hemostasis, and the growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market. Because of unhealthful eating habits, peptic ulcer cases are widespread worldwide, regardless of location. In addition, the prevalence of other stomach disorders including Peptic Ulcer Disease (PUD) is rising globally, which is driving up demand for gastrointestinal gadgets. Major market participants who are essential in determining consumer preferences and market dynamics have a major impact on the gastrointestinal bleeding treatment market.
★ Reviews
Rate this report
| Product type | Endoscopic hemostatic devices, Thermal devices, Closure devices |
| GI tract division | Upper GI Tract, Lower GI Tract |
| Onset | Acute, Chronic |
| End-User | Hospitals/clinics, Ambulatory surgical centers, Others. |
| List of Competitors | Boston Scientific Corporation, Olympus Corporation, CONMED Corporation, Cook Medical, Ovesco Endoscopy AG, Erbe Elektromedizin GmbH, STERIS PLC, US Medical Innovations LLC. |
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Gastrointestinal Bleeding Treatment Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Gastrointestinal Bleeding Treatment market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the gastrointestinal bleeding treatment ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.